Dr. Brian P. Beesley, M.D.
Family Medicine (Family Medicine Physician)
- Medicare participating
At a glance
- Medical school
- University of Utah School of Medicine (2011)
- Years since graduation
- 15
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 283
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Medical school: University of Utah School of Medicine
- 2011Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Medicine Physician primary
ID license M-12490
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mountain View Hospital Idaho Falls, ID
- Eastern Idaho Regional Medical Center Idaho Falls, ID
- Madison Memorial Hospital Rexburg, ID
Medical groups
- Madison Co Memorial Hospital (34 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 283
- Services billed
- 2,477
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 438 | 201 |
| Insertion of needle into vein for collection of blood sample | 258 | 190 |
| Blood test, comprehensive group of blood chemicals | 177 | 146 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 117 | 105 |
| Established patient office or other outpatient visit, 40-54 minutes | 110 | 69 |
| Hemoglobin a1c level | 97 | 70 |
| Blood test, lipids (cholesterol and triglycerides) | 87 | 84 |
| Blood test, thyroid stimulating hormone (tsh) | 79 | 71 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 77 | 77 |
| Blood test, clotting time | 65 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 2 payments worth $46.02 in total to this clinician.
| Gilead Sciences, Inc. | $46.02 |
|---|
| Food and Beverage | $46.02 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 2 companies. The companies reported $91,635 in research payments for these studies, mostly to the institutions running them.
- A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin
Eli Lilly and Company · Completed · NCT06192108 - A parallel-group treatment, phase 2, double-blind study of once-weekly subcutaneous LY3457263 compared to placebo in participants with type 2 diabetes mellitus on a stable dose of tirzepatide or semaglutide who failed…
Eli Lilly and Company - A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
Eli Lilly and Company · Completed · NCT05803421 - A parallel-group treatment, phase 2, double-blind study of once-weekly subcutaneous LY3457263 compared to placebo in participants with type 2 diabetes mellitus on a stable dose of tirzepatide or semaglutide who failed…
Eli Lilly Export S.a. Puerto Rico Branch
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.